Specialty Pharmacy

New software platform will complement existing pharmacy software and optimize patient management.

The FDA refused to approve Novo Nordisk's ultra-long-acting insulin treatments 2 years ago.

Vast majority of children with HIV experience recovery of immune system following therapy.

Researchers suggest financial incentives to reward patient-centered care.

Companies to jointly market software to health care providers.

The FDA has granted orphan drug designation to Prolong Pharmaceuticals' sickle cell disease treatment.

Enzyme blocker reduces growth of intestinal tumors.

Prevalence of tanning linked to sharp increase in melanoma risk.

The FDA has granted 2 breakthrough therapy designations to grazoprevir/elbasvir.

Private insurers and Medicare patients can pay up to 43 times less than the uninsured.

Study finds 1 in 5 Medicare patients have surgery delayed.

Making intravenous bag labels more legible could prevent medication errors during high-stress clinical situations.

HIV antiviral therapy can prevent infection from establishing in at-risk individuals.

Enzyme blocker shows potential in treating infections such as Ebola virus.

Pharmacy Times today joins with Cash Wise Pharmacy, Bashas' and Good Neighbor Pharmacy as it expands its Strategic Alliance Partnership (SAP) program. Sister publication Specialty Pharmacy Times added Avita and Biologics to its roster of strategic alliances.

Well-trained pharmacists can successfully screen patients for COPD in the community setting.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses methods specialty pharmacies can use to enhance adherence in patients with multiple sclerosis.

HIV patients need to have undetectable viral load to undergo procedure.

Glioblastoma Multiforme treatment may extend current one year survival rate.

While effective coordination during a patient's transition from hospital to home can improve outcomes, the process is frequently hindered by poor communication between hospital clinicians and primary care providers.

Drug could eventually also treat prostate cancer.

Drug failed in treatment of solid tumors but shows promise blocking amyloid-beta plaques.

A New York pharmacist was sentenced to 3 years in prison and will have to pay more than $7 million in restitution for his scheme to defraud Medicare, Medicaid, and an AIDS program.

Natural extract found to reduce cell growth in triple negative breast cancer.

Specialty drugs comprise 28% of total drug costs from just 1% of claims.

Anti-infective and cancer drugs saw the most approvals last year.

Less toxic drug class combined with fasting may kill breast, lung, and colon cancer cells equally well.

Medication would require no refrigeration and cost less than $1 per dose to manufacture.

Engineered protein improves survival rates in aggressive leukemia.

Crohn's disease specifically carries greater risk for developing cervical cancer.